Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-Small Cell Lung Cancer

This study has been suspended.

( Follow up only )

First Received: October 4, 2007 No Changes Posted

Sponsored by:	King Faisal Specialist Hospital & Research Center
Information provided by:	King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier:	NCT00540280

Purpose

Randomized Phase III trial of surgery alone or surgery plus preoperative Gemcitabine-Cisplatin in clinical early stages of non-small cell lung cancer

Condition	Intervention
Carcinoma, Non-Small-Cell Lung	Drug: Surgery alone or surgery plus preoperative Gemcitabine-Cisplatin

Study Type:	Interventional
Study Design:	Randomized, Open Label, Single Group Assignment

Resource links provided by NLM:

MedlinePlus related topics: Cancer Lung Cancer Surgery

Drug Information available for: Cisplatin Gemcitabine Gemcitabine hydrochloride

U.S. FDA Resources

Further study details as provided by King Faisal Specialist Hospital & Research Center:

Study Start Date:

October 2003

Eligibility

Genders Eligible for Study:

Both

Criteria

Inclusion Criteria:

Patients with early stage NSCLC

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00540280

Sponsors and Collaborators

King Faisal Specialist Hospital & Research Center

Investigators

Principal Investigator:

Khalid Rehman, MD

King Faisal Specialist Hospital & Research Centre, Saudi Arabia

More Information

No publications provided

Study ID Numbers:	RAC#2031-059
Study First Received:	October 4, 2007
Last Updated:	October 4, 2007
ClinicalTrials.gov Identifier:	NCT00540280 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by King Faisal Specialist Hospital & Research Center:

NSCLC

Study placed in the following topic categories:

Thoracic Neoplasms
Antimetabolites
Anti-Infective Agents
Immunologic Factors
Immunosuppressive Agents
Antiviral Agents
Carcinoma
Respiratory Tract Diseases

Cisplatin
Radiation-Sensitizing Agents
Lung Neoplasms
Lung Diseases
Non-small Cell Lung Cancer
Gemcitabine
Carcinoma, Non-Small-Cell Lung
Neoplasms, Glandular and Epithelial

Additional relevant MeSH terms:

Thoracic Neoplasms
Antimetabolites
Anti-Infective Agents
Antimetabolites, Antineoplastic
Immunologic Factors
Molecular Mechanisms of Pharmacological Action
Antineoplastic Agents
Physiological Effects of Drugs
Neoplasms by Site
Cisplatin
Respiratory Tract Diseases
Lung Neoplasms
Therapeutic Uses

Gemcitabine
Respiratory Tract Neoplasms
Neoplasms by Histologic Type
Enzyme Inhibitors
Antiviral Agents
Immunosuppressive Agents
Pharmacologic Actions
Carcinoma
Neoplasms
Radiation-Sensitizing Agents
Lung Diseases
Carcinoma, Non-Small-Cell Lung
Neoplasms, Glandular and Epithelial

ClinicalTrials.gov processed this record on August 28, 2009